Practical Strategies to Manage Fatigue on GLP-1 Therapy Nutrition optimization reduces fatigue during semaglutide treatment
Patients with diabetes immunized for influenza, zoster and meningococcus showed a 2-fold overall reduction in mortality risk and a decrease in hospitalizations
Retatrutide is being studied as a once-weekly shot, so the day-to-day work is familiar: shot day, site rotation, side effects, food, water, and the long weight trend
Recently, a real-world study showing association between incretin-based therapy and changes in taste perception with GLP-1 or dual GLP-1/GIP-RAs usage for around 40 weeks reported that independently to weight loss, there was an increase in sweet perception intensity up to 4.7 times and salt perception up to 3.2 times in around 20% of the participants, resulting as well in earlier satiety, and reduction of hunger and craving due to a major sensibilization to both flavors with any of these medication, although they did not mention further impact in weight loss or BMI change (170)
